Introduction
Emerging evidence suggests that the mechanistic target of rapamycin (mTOR) signaling functions as a placental nutrient sensor, regulating placental function and fetal growth in late pregnancy (Dimasuay et al., 2016) . Placental mTOR is activated in women with obesity or gestational diabetes mellitus (GDM) who deliver large babies and in animal models associated with fetal overgrowth Jansson et al., 2013; Capobianco et al., 2016; Perez-Perez et al., 2013) . In contrast, intrauterine growth restriction (IUGR) is characterized by inhibition of placental mTOR signaling in humans (Roos et al., 2007; Chen et al., 2015) and in animal models (Rosario et al., 2011; Kavitha et al., 2014) .
mTOR is a serine/threonine kinase that is activated by increased nutrient levels and growth factor signaling, thereby regulating gene transcription and protein translation to control multiple cellular processes that promote cell metabolism, growth and survival (Laplante and Sabatini, 2013; Shimobayashi and Hall, 2014) . mTOR forms two protein complexes, mTORC1 and mTORC2, in association with raptor or rictor, respectively (Shimobayashi and Hall, 2014) . Ribosomal protein S6 (rpS6) and 4E-binding protein 1 (4E-BP1) are downstream effectors of mTORC1 activation that positively regulate protein synthesis (Shimobayashi and Hall, 2014) . 4E-BP1 phosphorylation induces the release of the eukaryotic initiation factor 4E (elF4E), activating protein synthesis and cell growth (Laplante and Sabatini, 2013) . mTORC2 phosphorylates a number of targets, including serum and glucocorticoidinducible kinase 1 (SGK-1), with important roles in implantation (Lou et al., 2017) . Although mTOR signaling has been implicated in regulating implantation and trophoblast and embryo growth (Martin et al., 2003; Gardner and Harvey, 2015) , the function of mTOR signaling in the early post-implantation period remains to be determined.
In the post-implantation period, the decidua plays a fundamental nutritional role, providing histotrophic nutrition to allow embryo survival until the formation of a mature placenta (Burton et al., 2010; Filant and Spencer, 2014) . In murine embryos, the inverted yolk sac is crucial in histotrophic nutrition, as it is involved in the processes of endocytosis and pinocytosis of secretions from the uterine glands and decidual secretions (Holson et al., 2005; Zohn and Sarkar, 2010) . Lipoprotein particles are internalized in the yolk sac through the multiligand endocytic receptor complex for further repackage of lipids and transfer to the embryo (Herz and Farese, 1999; Zohn and Sarkar, 2010) . The secretions from decidual cells and endometrial glands are rich in lipid droplets (Burton et al., 2007) . Lipid droplets are characterized by the presence of the adipogenic protein perilipin 2 (PLIN2), which is considered a marker for the lipid load of non-adipogenic cells (Heid et al., 1998) . PLIN2 is transcriptionally regulated by peroxisome proliferator activated receptor γ (PPARγ) and PPARδ in trophoblasts and other cell types (Bildirici et al., 2003; Tobin et al., 2006) . In addition, fatty acid binding protein 4 (FABP4), a protein involved in intracellular and transcellular lipid transfer and relevant for decidual function (Tian et al., 2011) , is transcriptionally regulated by PPARγ (Tan et al., 2002) .
PPARs are transcription factors activated by ligands of lipid nature (e.g. mono-and polyunsaturated fatty acids) that function as master transcription factors to regulate gene expression in metabolic processes, critically important in maintaining lipid homeostasis and antioxidant/antiinflammatory responses (Wahli and Michalik, 2012) . Besides, they play relevant roles in embryo organogenesis and feto-placental development and metabolism (Jawerbaum and Capobianco, 2011; Kadam et al., 2015; Lendvai et al., 2016) . There are three PPAR isoforms, and among which, PPARγ and PPARδ play key roles in adipogenesis and are essential for embryo development (Barak et al., 2008; Barquissau et al., 2017; Wahli and Michalik, 2012) . Indeed, there are specific placental developmental defects in PPARγ and PPARδ null mice, which lead to embryo death, suggesting that both isoforms are essential and the absence of compensatory effects by other PPAR isoforms that rescue the adverse phenotype (Wang et al., 2007; Barak et al., 2008) . Our previous studies showed reduced embryonic PPARδ and decidual PPARγ in diabetic rats during early organogenesis, changes associated with impaired embryo morphogenesis (Higa et al., 2010 (Higa et al., , 2014 . Moreover, changes in fatty acid metabolism involve extensive PPAR and mTOR cross-talk in a variety of cell types (Ishiguro et al., 2006; Blanchard et al., 2012; Angela et al., 2016) and these nutrient signaling pathways share targets such as FABP4 (Wang et al., 2017) . In the current study, we hypothesized that there is a cross-talk between mTOR, PPARγ and PPARδ in the decidua that impacts post-implantation embryo survival and feto-placental growth. To test this hypothesis, we determined the effects of pharmacological inhibition of mTOR, PPARγ and PPARδ signaling during the early postimplantation period in pregnant rats.
Materials and Methods

Animals
Albino Wistar rats were obtained from the certified animal facility of the School of Exact and Natural Sciences, University of Buenos Aires (UBA, Argentina). In our animal facility (CEFYBO-CONICET, UBA, Argentina), rats received water and food ad libitum (commercial rat chow, Asociación Cooperativa Argentina, Buenos Aires, Argentina), on a lighting cycle of 12 h light:12 h dark. The animal protocol was approved by the Institutional Committee for the Care and Use of Experimental Animals (CICUAL, Resolution CD No. 1497 (Lee et al., 2002; Harston et al., 2011; Tsai et al., 2014) . The dosing interval was chosen aiming to address an early and presomite embryo post-implantation stage in which the decidua is crucial for embryo development and nutrition. Half of the animals were euthanized in a CO 2 chamber on Day 9 of pregnancy (3 h after the last injection) and the remainder on Day 14 of pregnancy. Using a stereomicroscope and microsurgical dissecting instruments, the balls of decidual tissue were explanted from each uterus on Day 9 of pregnancy (n = 7 dams in each experimental group). The decidua were prepared for immunohistochemical analyses of the levels of FABP4 and PLIN2, or homogenized in ice-cold buffer D (250 mM sucrose, 10 mM Hepes-Tris, pH 7.4) with protease inhibitor cocktail and phosphatase inhibitor cocktails 2 and 3 (Sigma Aldrich, Missouri, USA) and stored at −80°C for western blot analysis of PPARγ, PPARδ and functional readouts of the mTOR pathway. Decidua, fetuses and placentas from 14-day pregnant rats (n = 7 dams in each experimental group) were explanted from each uterus, examined morphologically under a stereomicroscope and weighed.
Immunohistochemistry
Immunostaining of FABP4 and PLIN2 was performed in the decidua of 9-day pregnant rats (n = 7 in each experimental group). Each decidua was paraffinized and serially sectioned (5 μm). Sections were deparaffinized, rehydrated through a graded series of ethanol and the endogenous peroxidase activity was blocked. The sections were processed using the corresponding primary antibodies: anti-FABP4 (rabbit polyclonal antibody (GTX54016), 1:100 dilution, GeneTex, CA, USA), and anti-PLIN-2 (mouse monoclonal antibody (LS-C348703 clone AP125), 1:100 dilution, LifeSpan BioSciences, Washington, USA). All primary antibodies were checked for antibody specificity by Western blot and diluted in PBSTween with 1% bovine serum albumin (BSA). Negative controls were performed in the absence of primary antibody and by replacing the primary antibody by a pooled serum of the same species that contains a spectrum of the IgG subclasses (Vector Laboratories, Burlingame, CA, USA). Biotinylated antibodies (anti-rabbit IgG or anti-mouse IgG-rat absorbed), 1:200 PBS-Tween in 1.5% normal horse serum (Vector Laboratories, Burlingame, CA, USA), were applied, followed by an incubation with an avidin-biotin complex for 60 min (Vector Laboratories). Staining was visualized by adding 40% w/v 3,3′-diaminobenzidine tetrahydrochloride chromogenbuffer plus 0.02% (v/v) hydrogen peroxide in 0.05 M Tris (pH 7.6) for 10 min (Martinez et al., 2012) . Three entire sections per decidua were examined using light microscopy by two skilled blinded observers. Immunoreactivity intensity was quantified using the ImageProPlus software. Data are shown as relative to a value of 1, arbitrarily assigned to the control. We also performed a semiquantitative score, which led to similar results (data not shown). In addition, also in the yolk sac and the uterine glands a semiquantitative score was performed.
Western blot analysis
Proteins from homogenates of pooled decidua from the same litter (n = 7 rats in each experimental group) were separated by SDS-PAGE and transferred to PVDF membranes (35 V constant, overnight at 4°C), as previously described (Capobianco et al., 2016) . The membranes were stained with Ponceau S staining solution for total proteins (Sigma-Aldrich) to confirm equal loading and transfer. Blocking was carried out for 1 h at room temperature in 1% BSA in TBS-Tween and membranes were incubated with the primary antibody (diluted in 1% BSA in TBS-Tween) overnight at 4°C. Protein expression of total and phosphorylated rpS6, total and phosphorylated 4E-BP1 was determined using antibodies (monoclonal 2217 clone 5G10 and polyclonal 2211, 9452 and 9459, respectively) from Cell Signaling Technology (Massachusetts, USA). Total and phosphorylated SGK-1 was evaluated using polyclonal antibodies (AF3200) from RyD Systems (Minnesota, USA) and (SC16745) from Santa Cruz (Texas, USA), respectively. PLIN2 was determined using antibodies from LifeSpan BioSciences (LS-C348703 clone AP125), while protein expression of PPARγ and PPARδ was determined using polyclonal antibodies (101 700 and 101 720, respectively) from Cayman Chemical Company, Michigan, USA. After washing, the membranes were incubated with the appropriate peroxidase conjugated secondary antibody and visualized using ECL detection solution (Thermo Scientific) and captured in a Chemiluminescence imaging system (GeneGnomeXRQ, Syngene). Densitometry analysis was performed with ImageJ software (Schneider et al., 2012) . The expression of the target protein in each individual lane was normalized for total protein staining to adjust for unequal loading. The mean of all the samples within a single gel was calculated and the expression of the target protein in each sample was calculated as a percentage of that mean (target/total protein).
Statistical analysis
Data are presented as the mean ± SEM. Groups were compared by Student t test or Chi-square test as appropriate. A P < 0.05 was considered statistically significant.
Results
Effects of inhibition of mTOR signaling in the early post-implantation period
Aiming to address the impact of mTOR inhibition limited to an early post-implantation period, rapamycin (0.75 mg/kg, sc) was administered to pregnant rats on Days 7, 8 and 9 of pregnancy and the decidua were evaluated 3 h after the last injection on Day 9 of pregnancy. Rapamycin administration led to more than 50% reduction in the phosphorylation of downstream targets of mTORC1 (rpS6 and 4E-BP1) and mTORC2 (SGK-1) in the decidua ( Supplementary  Fig. S1 ). We determined the protein expression of FABP4 and found that the inhibition of mTOR signaling resulted in a 22% reduction of FABP4 levels in the decidua (P < 0.05), when compared to control rats (Fig. 1) . A similar pattern of expression was observed in decidual cells and in the uterine glands, although only a weak staining, which did not change with the rapamycin treatment, was observed in the yolk sac (Fig. 1) . We next evaluated the protein expression of PLIN2 and found that the inhibition of mTOR signaling resulted in a 25% increase in decidual PLIN2 levels (P < 0.01) when compared to controls (Fig. 1) . This increase was also observed when PLIN2 protein Figure 1 Effect of in vivo treatments with the mTOR inhibitor rapamycin during Days 7-9 of pregnancy on decidual protein levels of (a) FABP4, (b) PLIN2, (c) PPARγ and (d) PPARδ, evaluated on Day 9 of pregnancy. Values represent mean ± SEM obtained from seven rats in each experimental group. Statistical analysis: Student t test. *P < 0.05, **P < 0.01 and ***P < 0.001 versus control. Representative photos of FABP4 and PLIN2 in the decidua, yolk sac and uterine glands are shown. D, decidua. E, embryo. White arrows point to the yolk sac. Black arrows point to immunostained uterine gland cells. levels were determined by western blot analysis ( Supplementary  Fig. S2 ). Different from decidual cells, only a weak PLIN2 staining was observed in the uterine glands, although the yolk sac showed a strong PLIN2 staining, which increases when mTOR signaling was inhibited (Fig. 1) . As PLIN2 is a classical PPAR target involved in the formation of lipid droplets (Heid et al., 1998; Bildirici et al., 2003) , and mTOR and PPAR cross-talk has been described in different tissues/cell types (Blanchard et al., 2012; Angela et al., 2016) , we next measured the protein expression of PPARγ and PPARδ. We observed that mTOR inhibition caused an increase in the protein levels of both PPARγ (36%, P < 0.05) and PPARδ (87%, P < 0.001) in the decidua (Fig. 1) .
Effects of inhibition of PPARγ signaling in the early post-implantation period
To next address the effect of PPARγ inhibition limited to an early postimplantation stage, the PPARγ inhibitor T0070907 (0.001 mg/kg, sc) was administered to rats on Days 7-9 of pregnancy and the decidua were evaluated on Day 9 of pregnancy. PPARγ inhibition led to a decrease in the protein levels of FABP4 (40%) in the decidua when compared to controls (P < 0.01, Fig. 2) . A reduced FABP4 expression was also observed in the uterine glands, although only a weak staining was observed in the yolk sac in both the control and the PPARγ inhibited groups (Fig. 2) . The inhibition of PPARγ led to a decrease in the Figure 2 Effect of in vivo treatments with the PPARγ inhibitor T0070907 during Days 7-9 of pregnancy on decidual protein levels of (a) FABP4 and (b) PLIN2, evaluated on Day 9 of pregnancy. Values represent mean ± SEM obtained from seven rats in each experimental group. Statistical analysis: Student t test. **P < 0.01 versus control. Representative photos of FABP4 and PLIN2 in the decidua, yolk sac and uterine glands are shown. D, decidua. E, embryo. White arrows point to the yolk sac. Black arrows point to immunostained uterine gland cells.
protein levels of PLIN2 (51%) in the decidua when compared to controls (P < 0.01, Fig. 2) . A decrease was also evidenced when decidual PLIN2 protein levels were determined by western blot analysis ( Supplementary Fig. S2 ). In contrast to decidual cells, only a weak PLIN2 staining was observed in the uterine glands from the control and the PPARγ inhibited group. Similarly to decidual cells, PLIN2 levels were reduced in the yolk sac when PPARγ was inhibited (Fig. 2) . In addition, PPARγ inhibition decreased the phosphorylation of rpS6 (P < 0.01) by a 25% without affecting total rpS6 levels in the decidua, whereas it did not change the levels of total and phosphorylated 4E-BP1 compared to controls (Fig. 3) . Moreover, we observed a marked reduction of phosphorylated SGK-1 (50%, P < 0.01), despite unchanged total SGK-1 levels in the decidua from T0070907-treated pregnant rats compared to controls (Fig. 3) . Collectively, these data demonstrate that inhibition of decidual PPARγ inhibits mTORC1 and mTORC2 signaling.
Effects of inhibition of PPARδ signaling in the early post-implantation period
To address the effect of PPARδ inhibition limited to an early postimplantation period, the PPARδ inhibitor GSK0660 (0.1 mg/kg, sc) was administered to rats on days 7 to 9 of pregnancy and the decidua were evaluated on Day 9 of pregnancy. PPARδ inhibition did not alter decidual FABP4 protein levels compared to controls (Fig. 4) . Similarly, PPARδ inhibition did not change FABP4 levels in the uterine glands (Fig. 4) . Only a weak FABP4 staining was detected in the yolk sac from rats treated or not with the PPARδ inhibitor (Fig. 4) . The inhibition of PPARδ led to a decrease in the protein levels of PLIN2 (37%) in the decidua when compared to controls (P < 0.01, Fig. 4) . A similar decrease was evidenced when decidual PLIN2 levels were determined by western blot analysis ( Supplementary Fig. S2 ). In the uterine glands, only a weak PLIN2 staining was observed in both the control and the PPARδ inhibited groups (Fig. 4) . Differently, the yolk sac showed a strong PLIN2 staining, which diminished when PPARδ was inhibited, similarly to that observed in decidual cells (Fig. 4) .
With respect to cross-talk with mTOR pathways, PPARδ inhibition did not affect the total expression or phosphorylation of rpS6 in the decidua, but markedly increased 4E-BP1 phosphorylation by a 73% (P < 0.001, Fig. 5 ) compared to controls, without affecting the total levels of this protein, suggesting the activation of this branch of the mTORC1 signaling pathway. In contrast, decidual levels of phosphorylated SGK-1 were found to be reduced by 53% (P < 0.001, Fig. 5 ) following PPARδ inhibition, whereas no changes in the levels of total SGK-1 were observed, suggesting the inhibition of the mTORC2 signaling pathway.
Effects of mTOR and PPAR signaling inhibition on resorption rates and growth capacity
The number of viable embryos and the resorption rate on Day 9 of pregnancy were similar in the control rats and in the rats that received the mTOR inhibitor (rapamycin 0.75 mg/kg, sc) from Days 7 to 9 of pregnancy (Fig. 6) . To further assess the effects of mTOR inhibition in the early post-implantation period on embryo viability and growth capacity, we evaluated the conceptus on Day 14 of pregnancy following administration of vehicle (control) or the mTOR inhibitor (rapamycin 0.75 mg/kg) from Days 7 to 9 of pregnancy. On Day 14 of pregnancy, a dramatic (92%) decrease in the number of viable fetuses per rat (P < 0.001) and an increased resorption rate (P < 0.001) were evident in the group that received the mTOR inhibitor compared to controls (Fig. 6) . Indeed, most fetuses were resorbed, and the few fetuses that survived to Day 14 of pregnancy displayed morphological Figure 3 Effect of in vivo treatments with the PPARγ inhibitor T0070907 during Days 7-9 of pregnancy on decidual protein levels of (a) phosphorylated and total rpS6, (b) phosphorylated and total 4E-BP1 and (c) phosphorylated and total SGK-1, evaluated on Day 9 of pregnancy. Values represent mean ± SEM obtained from seven rats in each experimental group. Statistical analysis: Student t test. **P < 0.01 versus control.
alterations and a severe developmental delay likely leading to future resorptions (Fig. 7) .
In the rats that received the PPARγ inhibitor (T0070907 0.001 mg/kg, sc) from Days 7 to 9 of pregnancy, the number of viable embryos and the resorption rate on Day 9 of pregnancy were similar to those of control rats and remained similar on Day 14 of pregnancy (Fig. 8) . The inhibition of PPARγ did not affect gross fetal morphology on Day 14 of pregnancy (Fig. 7) , but the reduced crown-rump length (P < 0.001) (Fig. 8) indicated a growth delay. In addition, placental weight was markedly reduced (51%, P < 0.001) following PPARγ inhibition, although decidual weight was unchanged when compared to controls (Fig. 8) .
In the rats that received the PPARδ inhibitor (GSK0660 0.1 mg/kg, sc) from Days 7 to 9 of pregnancy, the number of viable embryos and the resorption rate on Day 9 of pregnancy were similar to those of control rats (Fig. 9) . However, on Day 14 of pregnancy, the rats that received the PPARδ inhibitor during the early post-implantation period showed a reduction in the number of viable fetuses (P < 0.05) and an increased resorption rate (P < 0.01) as compared to controls (Fig. 9) . Although there were no gross malformations on the 14-day fetuses in the group that received the PPARδ inhibitor (Fig. 7) , they were growth restricted, as indicated by their reduced crown-rump length (P < 0.01) (Fig. 9) . Furthermore, PPARδ inhibition was associated with reduced placental weight (35%, P < 0.01), and increased decidual weight on Day 14 of pregnancy (35%, P < 0.001) (Fig. 9) .
Discussion
Following implantation and before the mature placenta is established, the embryo relies on histotrophic nutrition through secretions from decidual cells and endometrial glands in both humans and rodents (Burton et al., 2010; Filant and Spencer, 2014) . In rodents, the inverted yolk sac favors the absorption of nutrients (Zohn and Sarkar, 2010) . Although the role of placental mTOR and PPARs as nutrient sensors in late pregnancy is established, the function of these signaling pathways in regulating histotrophic nutrition in the early post-implantation period is largely unknown. We report for the first time that when mTOR, PPARγ or PPARδ pathways are inhibited in the early post-implantation period, a complex cross-talk between these signaling pathways is observed in the decidua, leading to reduced levels of adipogenic proteins relevant for histotrophic nutrition. Specifically, although inhibition Figure 5 Effect of in vivo treatments with the PPARδ inhibitor GSK0660 during Days 7 to 9 of pregnancy on decidual protein levels of (a) phosphorylated and total rpS6, (b) phosphorylated and total 4E-BP1 and (c) phosphorylated and total SGK-1, evaluated on Day 9 of pregnancy. Values represent mean ± SEM obtained from seven rats in each experimental group. Statistical analysis: Student t test. ***P < 0.001 versus control. of these nutrient sensors does not affect early post-implantation embryo viability, it leads to embryo loss, growth delay or placental/ decidual growth impairments in mid-gestation.
There is a growing interest in understanding the first trimester of human pregnancy, not only to improve the understanding of implantation failure and miscarriage but also in the search of possible early causes of pregnancy complications that typically are diagnosed later in pregnancy, including gestational diabetes and IUGR (Albu et al., 2014; Kennelly and McAuliffe, 2016) . The first trimester of pregnancy is characterized by histotrophic nutrition, which provides essential nutrients to the growing embryo and allows a proper placental development (Burton et al., 2010; Filant and Spencer, 2014) . To address the impact of nutrient sensors in the early post-implantation period, we administered mTOR, PPARγ and PPARδ inhibitors on Days 7-9 of rat pregnancy, a developmental stage corresponding to the very early post-implantation embryonic and placental development that occurs in the second week of human pregnancy. Our data reveal the importance of this early postimplantation period in determining fetal growth and identify distinct effects of the inhibition of mTOR, PPARγ or PPARδ signaling on decidual proteins relevant for histotrophic nutrition.
The inhibition of mTOR limited to this short post-implantation period had a pronounced impact on mid-gestation outcomes. Indeed, the resorption rate on Day 14 of pregnancy was extremely high and occurred despite the observed upregulation of PPARγ and PPARδ in the decidua, which may be compensatory. The cross-talk between mTOR and PPARs seems to be dependent on the tissue and cell type, as it is well described that in adipose tissue, mTOR activation stimulates PPARγ-induced lipid uptake and fat accretion (Kim and Chen, 2004; Blanchard et al., 2012) . The increased abundance of PLIN2 protein in the decidua is likely to be the result of PPARγ activation, given the well established role of PPARγ as a transcriptional regulator of PLIN2 in trophoblasts and other cell types (Bildirici et al., 2003) . In this study, PLIN2 levels were low in the uterine glands but high in the yolk sac, which show a further increase in their levels when mTOR is inhibited, suggesting a common regulation in the decidual cells and the yolk sac. mTOR inhibition caused a decrease in FABP4 protein expression, in both decidua and uterine glands, similarly to that observed in other cell types (Wang et al., 2017) , and despite PPARγ activation, which has been reported to positively regulate FABP4 in different tissues (Tan et al., 2002) .
Although it is well established that IUGR is associated with inhibition of placental mTORC1 and mTORC2 signaling (Roos et al., 2007; Rosario et al., 2011; Kavitha et al., 2014; Chen et al., 2015) , the severity of the phenotype observed in this work demonstrates that the early post-implantation period is highly susceptible to mTOR inhibition, implicating mTOR as a nutrient sensing and growth promoting signaling pathway critical for normal development and survival at this developmental stage. mTOR is important for the growth and survival of the trophoblast and embryo prior to implantation as evidenced by the lack of viability of mTOR null mice (Murakami et al., 2004) , and impaired trophoblast outgrowth following mTOR inhibition in pre-implantation embryos in culture (Martin et al., 2003) . These reports, together with the findings in the present study, are consistent with a critical role of mTOR in embryo viability from conception to the early postimplantation stage. In addition to the well-known role of mTOR modulating placental nutrient transport and mitochondrial respiration and thereby regulating fetal growth (Kavitha et al., 2014) , a recent study in which rapamycin was given to rats during late pregnancy has shown that mTOR signaling is involved in the programming of heart defects in the offspring (Hennig et al., 2017) . Moreover, placental mTOR signaling activity in IUGR correlates with growth during the first year of life (Fahlbusch et al., 2015) . Therefore, mTOR signaling appears to play an important role in determining growth and survival from early pregnancy to the postnatal period.
In the present study, a less severe phenotype was observed when PPARγ was inhibited in the early post-implantation period in the rat. Our results are consistent with a role for PPARγ as a nutrient sensor, capable of regulating the levels of FABP4 in the decidua and uterine glands and the levels of PLIN2 in the decidua and yolk sac, adipogenic proteins involved in cellular and tissue lipid metabolism (Heid et al., 1998; Li et al., 2018; Scifres et al., 2011) . As FABP4 is involved in decidualization and PLIN2 modulates lipid accumulation and transfer in different tissues, including the placenta (Bildirici et al., 2003; Scifres et al., 2011; Frank et al., 2015; Tian et al., 2011; Li et al., 2018) , the downregulation of these adipogenic proteins in the decidua, uterine glands and yolk sac may be directly linked to the feto-placental growth restriction observed following PPARγ inhibition. The proposed histotrophic and growth promoting role of these adipogenic proteins in the decidua is supported by the reported metabolic and histotrophic role of PLIN2 in tumor cell growth and the ability of FABP4 to regulate proliferation, Figure 7 Representative figures of fetuses obtained from 14-day pregnant rats that received (a) vehicle, (b) the mTOR inhibitor rapamycin, (c) the PPARγ inhibitor T0070907 and (d) the PPARδ inhibitor GSK0660 from Days 7 to 9 of pregnancy. migration and invasion of human uterine endometrial epithelial cells Koizume and Miyagi, 2016) .
Although diverse studies have shown that PPARγ activation negatively regulates mTOR signaling in different tissues (San et al., 2015; Osman and Segar, 2016; Capobianco et al., 2017) , by studying the decidua, we found that the activities of both mTORC1 and mTORC2 signaling pathways were reduced when the rats were treated with the PPARγ inhibitor. Despite this reduction, there was no increased resorption rate on Day 14 of pregnancy. The different outcomes in pregnancies in which mTOR was inhibited using rapamycin (causing a high resorption rate) and in pregnancies in which PPARγ was inhibited (associated with mTOR inhibition but no effect on resorption rates) may be related to a less pronounced inhibition of mTOR in rats following PPARγ inhibition as compared to rats treated with the mTOR inhibitor.
In rats treated with the PPARγ inhibitor during the early postimplantation period, both the reduction in levels of adipogenic proteins, which is expected to limit lipid transfer to the developing embryo (Bildirici et al., 2003; Scifres et al., 2011) , and the reduced mTOR signaling, expected to inhibit transfer of amino acids and cell growth Figure 8 Effect of in vivo treatments with the PPARγ inhibitor T0070907 during Days 7 to 9 of pregnancy on (a) the number of viable embryos per rat and the resorption rate on Day 9 of pregnancy and (b) the number of viable fetuses per rat, the resorption rate, the fetal crown-rump length and the placental and decidual weight on Day 14 of pregnancy. Values represent mean ± SEM obtained from seven rats in each experimental group. Statistical analysis: Student t test or Chi-square test (percentage of resorption data). ***P < 0.001 versus control. (Shimobayashi and Hall, 2014; Dimasuay et al., 2016) , may be involved in the reduced fetal and placental weight evidenced in the postplacentation period. The mechanisms linking the inhibition of critical nutrient sensing signaling pathways on Days 7-9 of gestation to the outcomes on Day 14 of pregnancy remain to be established but may involve epigenetic mechanisms or effects on stem/progenitor cell populations. Indeed, PPAR and mTOR signaling regulates epigenetic and stem cell differentiation in different tissues/cell types, leading to developmental and metabolic changes (Meyer et al., 2016; Vadla and Haldar, 2018) .
PPARδ inhibition in pregnant rats in the early post-implantation period caused no changes in FABP4 levels in the decidua and uterine glands, but resulted in a reduction in PLIN2 protein levels in the decidua and yolk sac, which may contribute to an impaired lipid histotrophic nutrition. To the best of our knowledge, PLIN2 has not been previously studied in the context of decidual function, but our data are consistent with the possibility that PLIN2 is regulated by mTOR and PPAR nutrient sensing pathways and is involved in histotrophic nutrition in early pregnancy. Indeed, the strong PLIN2 immunostaining evident in the inverted yolk sac suggests its contribution to the various Figure 9 Effect of in vivo treatments with the PPARδ inhibitor GSK0660 during Days 7-9 of pregnancy on (a) the number of viable embryos per rat and the resorption rate on Day 9 of pregnancy and (b) the number of viable fetuses per rat, the resorption rate, the fetal crown-rump length and the placental and decidual weight on Day 14 of pregnancy. Values represent mean ± SEM obtained from seven rats in each experimental group. Statistical analysis: Student t test or Chi-square test (percentage of resorption data). *P < 0.05, **P < 0.01 and ***P < 0.001 versus control. mechanisms described in the yolk sac that allow a proper transfer of lipids to the developing murine embryos (Herz and Farese, 1999; Zohn and Sarkar, 2010) .
PPARδ inhibition on Days 7-9 of pregnancy resulted in increased decidual levels of phosphorylated 4E-BP1, a branch of the mTORC1 pathway that promotes initiation of protein translation, thus leading to increased protein synthesis. It is possible that these changes contribute to the decidual overgrowth observed in this experimental group. On the other hand, decidual mTORC2 signaling was inhibited following PPARδ inhibition, which, together with the reduction of decidual PLIN2 levels, may have detrimental effects and lead to the reduced feto-placental growth evidenced on Day 14 of pregnancy. Moreover, embryo resorptions were also observed in this experimental group, highlighting an important role of PPARδ in the decidua in the early post-implantation period. These observations extend to the early post-implantation period the previously established critical role of PPARδ in implantation (Wang et al., 2007) .
Our results point to an impaired nutritional effect in the decidua, which leads to the adverse results observed in embryo and placental development. Nevertheless, as a limitation of this work, it is unknown whether some of these effects are secondary to systemic (endocrine) effects in the mother. Moreover, as PPARs and mTOR pathways are involved in angiogenic pathways in the placenta and other tissues/cell types (Wang et al., 2007; Jiang and Liu, 2008) , a possible regulation of angiogenic pathways that may be involved in the observed effects deserves further research. Finally, further studies addressing a rescue of the phenotype through mTOR and PPARs activation will be needed to improve the understanding of mTOR and PPAR signaling in embryo organogenesis.
In conclusion, our findings are consistent with an important role of decidual mTOR and PPAR nutrient sensing pathways in a very early post-implantation period. Possibly by regulating histotrophic nutrition, these nutrient sensors determine embryo viability and the growth of the placenta and the fetus.
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